Sumitomo Mitsui Trust Holdings, Inc. Moderna, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 110,698 shares of MRNA stock, worth $3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110,698
Previous 751,804
85.28%
Holding current value
$3 Million
Previous $21.3 Million
85.67%
% of portfolio
0.0%
Previous 0.02%
Shares
21 transactions
Others Institutions Holding MRNA
# of Institutions
861Shares Held
267MCall Options Held
28.5MPut Options Held
34.8M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.13 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$694 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$600 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$469 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$241 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...